TickerFiles

ACTUATE THERAPEUTICS, INC. 10-Q filing

Filed 2025-11-13 · Report date 2025-09-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001683168-25-008323
Form type
10-Q
CIK
0001652935
Primary document
https://www.sec.gov/Archives/edgar/data/1652935/000168316825008323/actuate_i10q-093025.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for ACTUATE THERAPEUTICS, INC..

Reported financial metrics

MetricCurrentPriorChange
Operating Income$-17.8M--
Net Income$-17.7M--
Eps Basic-0.88--
Eps Diluted-0.88--
Cash And Equivalents$16.9M--
Total Assets$17.7M--
Total Liabilities$6.8M--
Shareholders Equity$10.9M--
Operating Cash Flow$-15.5M--